EnvistaNVST
About: Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
Employees: 12,300
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
809% more call options, than puts
Call options by funds: $15.9M | Put options by funds: $1.75M
33% more funds holding in top 10
Funds holding in top 10: 3 [Q3] → 4 (+1) [Q4]
3% less capital invested
Capital invested by funds: $3.85B [Q3] → $3.72B (-$132M) [Q4]
1.56% less ownership
Funds ownership: 113.48% [Q3] → 111.92% (-1.56%) [Q4]
4% less funds holding
Funds holding: 292 [Q3] → 279 (-13) [Q4]
12% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 41
25% less repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 116
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Wells Fargo Vik Chopra 83% 1-year accuracy 10 / 12 met price target | 1%upside $21 | Equal-Weight Maintained | 6 Feb 2025 |
Morgan Stanley Erin Wright 50% 1-year accuracy 14 / 28 met price target | 4%downside $20 | Equal-Weight Maintained | 6 Feb 2025 |
Piper Sandler Jason Bednar 45% 1-year accuracy 17 / 38 met price target | 14%downside $18 | Neutral Maintained | 3 Feb 2025 |
Jefferies Glen Santangelo 60% 1-year accuracy 6 / 10 met price target | 5%upside $22 | Hold Maintained | 23 Jan 2025 |
Mizuho Steven Valiquette 40% 1-year accuracy 2 / 5 met price target | 4%downside $20 | Underperform Initiated | 4 Dec 2024 |
Financial journalist opinion
Based on 8 articles about NVST published over the past 30 days
